BIOA (STOCKS)
BioAge Labs, Inc. Common Stock
$10.430000
-0.050000 (-0.48%)
Prev close: $10.480000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Kristen Fortney
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $478.25M
- Employees
- 64
- P/E (TTM)
- -4.39
- P/B (TTM)
- 1.28
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
6
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.58 | $-0.62 | +0.0442 | +7.08% |
|
Mar 2026 (Q1)
|
$-0.52 | $-0.65 | +0.1328 | +20.34% |
|
Dec 2025 (Q4)
|
$-0.72 | $-0.75 | +0.0336 | +4.46% |
|
Sep 2025 (Q3)
|
$-0.56 | $-0.60 | +0.0359 | +6.02% |
Financial Statements
| Revenues | $10.36M |
| Benefits Costs and Expenses | $54.05M |
| Costs And Expenses | $111.02M |
| Nonoperating Income/Loss | $11.81M |
| Operating Expenses | $116.63M |
| Research and Development | $87.79M |
| Other Operating Expenses | $28.84M |
| Operating Income/Loss | -$106.27M |
| Income/Loss From Continuing Operations After Tax | -$94.46M |
| Income/Loss From Continuing Operations Before Tax | -$72.24M |
| Net Income/Loss | -$94.46M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$94.46M |
| Net Income/Loss Available To Common Stockholders, Basic | -$94.46M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.38 |
| Diluted Earnings Per Share | -$2.38 |
| Basic Average Shares | 123,252,295 |
| Diluted Average Shares | 123,252,295 |
| Assets | $396.93M |
| Current Assets | $330.31M |
| Noncurrent Assets | $66.62M |
| Fixed Assets | $1.21M |
| Other Non-current Assets | $65.41M |
| Liabilities | $22.02M |
| Current Liabilities | $19.22M |
| Accounts Payable | $5.65M |
| Wages | $3.54M |
| Other Current Liabilities | $10.03M |
| Noncurrent Liabilities | $2.80M |
| Equity | $374.91M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $374.91M |
| Liabilities And Equity | $396.93M |
| Net Cash Flow From Operating Activities | -$87.60M |
| Net Cash Flow From Operating Activities, Continuing | -$87.60M |
| Net Cash Flow From Investing Activities | -$212.85M |
| Net Cash Flow From Investing Activities, Continuing | -$212.85M |
| Net Cash Flow From Financing Activities | $154.15M |
| Net Cash Flow From Financing Activities, Continuing | $154.15M |
| Net Cash Flow | -$146.31M |
| Net Cash Flow, Continuing | -$146.31M |
| Comprehensive Income/Loss | -$95.15M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$95.15M |
| Other Comprehensive Income/Loss | -$20.86M |
| Other Comprehensive Income/Loss Attributable To Parent | -$690.00K |